FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

3486311000001100: Lidocaine 5% / Hydrocortisone acetate 0.275% ointment (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
15211701000001118 Lidocaine 5% / Hydrocortisone acetate 0.275% ointment (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
15211801000001110 Lidocaine 5% / Hydrocortisone acetate 0.275% ointment en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lidocaine 5% / Hydrocortisone acetate 0.275% ointment Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route ointment.cutaneous ontology form and route true Inferred relationship Existential restriction modifier
Lidocaine 5% / Hydrocortisone acetate 0.275% ointment Has NHS dm+d (dictionary of medicines and devices) dose form indicator Continuous dose form indicator true Inferred relationship Existential restriction modifier
Lidocaine 5% / Hydrocortisone acetate 0.275% ointment Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Topical route false Inferred relationship Existential restriction modifier
Lidocaine 5% / Hydrocortisone acetate 0.275% ointment Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lidocaine 5% / Hydrocortisone acetate 0.275% ointment Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Cutaneous true Inferred relationship Existential restriction modifier
Lidocaine 5% / Hydrocortisone acetate 0.275% ointment Has active ingredient Hydrocortisone acetate false Inferred relationship Existential restriction modifier
Lidocaine 5% / Hydrocortisone acetate 0.275% ointment Has manufactured dose form Ointment false Inferred relationship Existential restriction modifier
Lidocaine 5% / Hydrocortisone acetate 0.275% ointment Has active ingredient Lidocaine false Inferred relationship Existential restriction modifier
Lidocaine 5% / Hydrocortisone acetate 0.275% ointment Is a Product containing hydrocortisone and lidocaine false Inferred relationship Existential restriction modifier
Lidocaine 5% / Hydrocortisone acetate 0.275% ointment Has manufactured dose form Ointment false Inferred relationship Existential restriction modifier
Lidocaine 5% / Hydrocortisone acetate 0.275% ointment VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lidocaine 5% / Hydrocortisone acetate 0.275% ointment Is a Lidocaine + Hydrocortisone true Inferred relationship Existential restriction modifier
Lidocaine 5% / Hydrocortisone acetate 0.275% ointment VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lidocaine 5% / Hydrocortisone acetate 0.275% ointment Has specific active ingredient Hydrocortisone acetate true Inferred relationship Existential restriction modifier
Lidocaine 5% / Hydrocortisone acetate 0.275% ointment Has specific active ingredient Lidocaine true Inferred relationship Existential restriction modifier
Lidocaine 5% / Hydrocortisone acetate 0.275% ointment Has active ingredient Hydrocortisone false Inferred relationship Existential restriction modifier
Lidocaine 5% / Hydrocortisone acetate 0.275% ointment Has dispensed dose form Ointment true Inferred relationship Existential restriction modifier
Lidocaine 5% / Hydrocortisone acetate 0.275% ointment Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Lidocaine 5% / Hydrocortisone acetate 0.275% ointment Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Lidocaine 5% / Hydrocortisone acetate 0.275% ointment Has manufactured dose form Ointment false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Xyloproct ointment (AstraZeneca) Is a True Lidocaine 5% / Hydrocortisone acetate 0.275% ointment Inferred relationship Existential restriction modifier
Lidocaine 5% / Hydrocortisone acetate 0.275% ointment 30 gram Is pack of False Lidocaine 5% / Hydrocortisone acetate 0.275% ointment Inferred relationship Existential restriction modifier
Lidocaine 5% / Hydrocortisone acetate 0.275% ointment 20 gram Is pack of False Lidocaine 5% / Hydrocortisone acetate 0.275% ointment Inferred relationship Existential restriction modifier
Lidocaine 5% / Hydrocortisone acetate 0.275% ointment 20 gram Has VMP True Lidocaine 5% / Hydrocortisone acetate 0.275% ointment Inferred relationship Existential restriction modifier
Lidocaine 5% / Hydrocortisone acetate 0.275% ointment 30 gram Has VMP True Lidocaine 5% / Hydrocortisone acetate 0.275% ointment Inferred relationship Existential restriction modifier
Lidocaine 5% / Hydrocortisone acetate 0.275% ointment (Ennogen Healthcare Ltd) Is a False Lidocaine 5% / Hydrocortisone acetate 0.275% ointment Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start